ArticleNature biomedical engineering2026

Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence.

Yannik Kaiser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.